GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC-CFI_628/2024 and UPC_CFI_125/2025

Emboline, Inc. v. AorticLab srl

Datum
2026-01-13
Kammer
Munich (DE) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC-CFI_628-2024-and-UPC_CFI_125-2025-aec6fe7f8548
Aktenzeichen
RegisterzeichenUPC-CFI_628/2024 and UPC_CFI_125/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 29

Decision on the merits of the Court of First Instance of the Unified Patent Court Local Division Munich issued on 13 January 2026 HEADNOTES: 1. Patent infringement is not excluded by the fact that a device is normally operated in a non-infringing manner and customers therefore do not regularly make use of the patent ed teaching, as long as the use of the patented teaching remains possible when using the device. In the case of a medical device, however, the possibility of an irregular but patent- compliant use can only be considered as patent infringement if such use is in line with professional practice and the recognised rules of medical science. 2. The unconditional transition from a counterclaim to a dependent counterclaim, which is dependent on the occurrence of an intra -procedural co ...